Allianz Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $417M | Buy |
6,879,864
+1,384,478
| +25% | +$80.7M | 0.44% | 37 |
|
|
2025
Q4 | $296M | Buy |
5,495,386
+298,434
| +6% | +$14.4M | 0.3% | 55 |
|
|
2025
Q3 | $234M | Buy |
5,196,952
+680,116
| +15% | +$31.8M | 0.26% | 66 |
|
|
2025
Q2 | $209M | Buy |
4,516,836
+1,245,729
| +38% | +$61.2M | 0.25% | 81 |
|
|
2025
Q1 | $200M | Sell |
3,271,107
-151,357
| -4% | -$8.82M | 0.26% | 74 |
|
|
2024
Q4 | $194M | Buy |
3,422,464
+1,900,267
| +125% | +$106M | 0.26% | 78 |
|
|
2024
Q3 | $78.8M | Buy |
1,522,197
+38,932
| +3% | +$1.83M | 0.11% | 201 |
|
|
2024
Q2 | $61.6M | Sell |
1,483,265
-418,262
| -22% | -$18.7M | 0.09% | 222 |
|
|
2024
Q1 | $103M | Buy |
1,901,527
+177,293
| +10% | +$9.03M | 0.16% | 145 |
|
|
2023
Q4 | $88.5M | Buy |
1,724,234
+210,694
| +14% | +$11.1M | 0.14% | 146 |
|
|
2023
Q3 | $87.8M | Sell |
1,513,540
-235,373
| -13% | -$14.4M | 0.15% | 143 |
|
|
2023
Q2 | $112M | Sell |
1,748,913
-223,464
| -11% | -$15M | 0.2% | 111 |
|
|
2023
Q1 | $137M | Buy |
1,972,377
+84,443
| +4% | +$5.96M | 0.24% | 78 |
|
|
2022
Q4 | $136M | Buy |
1,887,934
+154,398
| +9% | +$11.6M | 0.26% | 79 |
|
|
2022
Q3 | $123M | Sell |
1,733,536
-728,826
| -30% | -$52.9M | 0.25% | 82 |
|
|
2022
Q2 | $190M | Buy |
2,462,362
+1,135,798
| +86% | +$86.5M | 0.18% | 125 |
|
|
2022
Q1 | $96.9M | Sell |
1,326,564
-396,782
| -23% | -$26.6M | 0.07% | 289 |
|
|
2021
Q4 | $107M | Sell |
1,723,346
-469,587
| -21% | -$27.5M | 0.07% | 284 |
|
|
2021
Q3 | $130M | Sell |
2,192,933
-38,941
| -2% | -$2.56M | 0.1% | 220 |
|
|
2021
Q2 | $149M | Buy |
2,231,874
+122,915
| +6% | +$8.01M | 0.13% | 170 |
|
|
2021
Q1 | $133M | Sell |
2,108,959
-2,319,376
| -52% | -$144M | 0.13% | 170 |
|
|
2020
Q4 | $275M | Sell |
4,428,335
-63,670
| -1% | -$3.92M | 0.27% | 85 |
|
|
2020
Q3 | $271M | Sell |
4,492,005
-2,407,688
| -35% | -$145M | 0.31% | 66 |
|
|
2020
Q2 | $406M | Buy |
6,899,693
+854,709
| +14% | +$51.1M | 0.47% | 38 |
|
|
2020
Q1 | $337M | Sell |
6,044,984
-1,390,560
| -19% | -$85M | 0.45% | 37 |
|
|
2019
Q4 | $477M | Buy |
7,435,544
+2,615,527
| +54% | +$150M | 0.44% | 29 |
|
|
2019
Q3 | $244M | Sell |
4,820,017
-927,558
| -16% | -$43.6M | 0.24% | 82 |
|
|
2019
Q2 | $261M | Buy |
5,747,575
+570,472
| +11% | +$26.6M | 0.24% | 76 |
|
|
2019
Q1 | $247M | Buy |
5,177,103
+1,032,683
| +25% | +$51.4M | 0.24% | 82 |
|
|
2018
Q4 | $215M | Buy |
4,144,420
+540,143
| +15% | +$29M | 0.24% | 85 |
|
|
2018
Q3 | $224M | Buy |
3,604,277
+644,287
| +22% | +$38.2M | 0.2% | 92 |
|
|
2018
Q2 | $164M | Sell |
2,959,990
-36,478
| -1% | -$1.97M | 0.16% | 132 |
|
|
2018
Q1 | $190M | Buy |
2,996,468
+49,780
| +2% | +$3.2M | 0.18% | 116 |
|
|
2017
Q4 | $181M | Buy |
2,946,688
+295,747
| +11% | +$18.5M | 0.14% | 149 |
|
|
2017
Q3 | $169M | Sell |
2,650,941
-91,920
| -3% | -$5.37M | 0.15% | 143 |
|
|
2017
Q2 | $153M | Buy |
2,742,861
+95,898
| +4% | +$5.22M | 0.15% | 145 |
|
|
2017
Q1 | $144M | Sell |
2,646,963
-461,184
| -15% | -$25.3M | 0.14% | 149 |
|
|
2016
Q4 | $182M | Sell |
3,108,147
-404,325
| -12% | -$22.1M | 0.16% | 138 |
|
|
2016
Q3 | $189M | Buy |
3,512,472
+632,002
| +22% | +$40.6M | 0.18% | 114 |
|
|
2016
Q2 | $212M | Sell |
2,880,470
-885,399
| -24% | -$62.6M | 0.23% | 88 |
|
|
2016
Q1 | $241M | Buy |
3,765,869
+159,532
| +4% | +$10.1M | 0.27% | 77 |
|
|
2015
Q4 | $248M | Buy |
3,606,337
+77,042
| +2% | +$5.09M | 0.28% | 70 |
|
|
2015
Q3 | $209M | Buy |
3,529,295
+131,139
| +4% | +$8.32M | 0.25% | 82 |
|
|
2015
Q2 | $226M | Sell |
3,398,156
-594,361
| -15% | -$39.2M | 0.24% | 81 |
|
|
2015
Q1 | $258M | Buy |
3,992,517
+100,536
| +3% | +$6.29M | 0.29% | 77 |
|
|
2014
Q4 | $230M | Buy |
3,891,981
+171,881
| +5% | +$9.69M | 0.26% | 81 |
|
|
2014
Q3 | $190M | Buy |
3,720,100
+127,586
| +4% | +$6.37M | 0.23% | 96 |
|
|
2014
Q2 | $174M | Sell |
3,592,514
-134,453
| -4% | -$6.63M | 0.22% | 106 |
|
|
2014
Q1 | $194M | Sell |
3,726,967
-133,928
| -3% | -$7.13M | 0.23% | 91 |
|
|
2013
Q4 | $205M | Sell |
3,860,895
-73,526
| -2% | -$3.75M | 0.26% | 83 |
|
|
2013
Q3 | $182M | Buy |
3,934,421
+1,468,221
| +60% | +$64.4M | 0.24% | 91 |
|
|
2013
Q2 | $110M | Buy |
+2,466,200
| New | +$107M | 0.16% | 151 |
|
Other funds holding BMY
VCM
VPM
Allianz Asset Management's BMY Position: Q1 2026 in Review
Allianz Asset Management increased its Bristol-Myers Squibb (BMY) stake by 25% in Q1 2026, buying an estimated $80.7M and bringing the position to 6,879,864 shares worth $417M. The position accounts for 0.44% of the portfolio, ranked #37.
Allianz Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $477M in Q4 2019. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Allianz Asset Management held 6,879,864 shares of Bristol-Myers Squibb worth $417M as of Q1 2026.
- Allianz Asset Management bought 1,384,478 Bristol-Myers Squibb shares in Q1 2026, an estimated $80.7M.
- Bristol-Myers Squibb made up 0.44% of Allianz Asset Management's portfolio in Q1 2026, its #37 holding.
- Allianz Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Bristol-Myers Squibb position peaked at $477M in Q4 2019.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.